KURA
Kura Oncology Inc
Price:  
7.14 
USD
Volume:  
1,535,925.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KURA WACC - Weighted Average Cost of Capital

The WACC of Kura Oncology Inc (KURA) is 8.6%.

The Cost of Equity of Kura Oncology Inc (KURA) is 8.65%.
The Cost of Debt of Kura Oncology Inc (KURA) is 7.00%.

Range Selected
Cost of equity 6.80% - 10.50% 8.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.7% - 10.4% 8.6%
WACC

KURA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 1.01
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 10.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.02 0.02
Cost of debt 7.00% 7.00%
After-tax WACC 6.7% 10.4%
Selected WACC 8.6%